Literature DB >> 30864527

A Comprehensive Review on the Screening Models for the Pharmacological Assessment of Antiulcer Drugs.

Abhinav P Mishra1, Ankit Bajpai1, Suresh Chandra1.   

Abstract

BACKGROUND: Due to inappropriate diet, smoking, alcohol consumption, regular use of drugs like NSAIDs and sedentary lifestyle, one may feel upper abdominal pain which may be the predictor of the gastrointestinal disorder called Peptic Ulcer. When an imbalance occurs between the defensive factor and aggressive factor of the stomach, ulcer formation in the esophageal lining, stomach, or duodenum takes place. This leads to the formation of small sores that cause pain. Another condition that synergizes the abdominal pain is vomiting materials which look like coffee grounds, blood in the stool, black or tarry stools. This pain may increase after lunch or dinner. This problem persists, that often leads to the gastroenterologist's consultation.
OBJECTIVE: There are many antiulcer screening models present for the determination of antiulcer activity of the drug molecule. The main objective of this study is to find which model is best for the determination of antiulcer activity.
METHODS: A literature search was conducted on the databases namely Science direct and PubMed with the help of different keywords such as "Anti-ulcer", "In-vitro models" and "In-vivo models". The search was customized by applying the appropriate filters so as to get the most relevant articles to meet the objective of this review article. RESULT: There are different research and review papers based on the antiulcer screening models for the determination of antiulcer activity of new drug molecules.
CONCLUSION: On the basis of our study, we found some useful models for the antiulcer activity of drugs and suggested that, if we use in-vitro and in-vivo methods together, then we may obtain the most relevant result in our research area. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Helicobacter pylori; NSAIDs; cushing ulcer; cysteamine; histamine; proton pump inhibitor.

Mesh:

Substances:

Year:  2019        PMID: 30864527     DOI: 10.2174/1574884714666190312143846

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  4 in total

1.  Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage.

Authors:  Sherien A Abdelhady; Mennatallah A Ali; Tamer A Al-Shafie; Ebtsam M Abdelmawgoud; Dalia M Yacout; Mahmoud M El-Mas
Journal:  Inflamm Res       Date:  2021-08-11       Impact factor: 4.575

2.  Gastroprotective Effects of the Aqueous Extract from Taraxacum officinale in Rats Using Ultrasound, Histology, and Biochemical Analysis.

Authors:  Maria Eduarda D C Zanatta; Daniela Miorando; Amanda M Stefller; Nátali Roos; Jackeline Ernetti; Ana Júlia Predebon; Heloísa Lindemann; Aline Mânica; Beatriz M M Oliveira; Patrícia Z Serpa; Lilian Bohnen; Viviane Simomura; Denise B Gomes; Max Vidal-Gutiérrez; Wagner Vilegas; Luisa M Silva; Walter A Roman Junior
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-21       Impact factor: 2.629

3.  Effect of a Cytoprotective Dose of Dehydroleucodine, Xanthatin, and 3-Benzyloxymethyl-5H-furan-2-one on Gastric Mucosal Lesions Induced by Mast Cell Activation.

Authors:  Mariano Ezequiel Vera; María Laura Mariani; Cristina Aguilera; Alicia Beatriz Penissi
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

4.  Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico Approach.

Authors:  Melina Luzzi Zarricueta; Felipe Leonardo Fagundes; Quélita Cristina Pereira; Simone Queiroz Pantaleão; Raquel de Cássia Dos Santos
Journal:  Pharmaceutics       Date:  2022-03-04       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.